募集资金使用

Search documents
聚石化学: 天风证券股份有限公司关于广东聚石化学股份有限公司归还募集资金及使用剩余超募资金永久补充流动资金的核查意见
Zheng Quan Zhi Xing· 2025-08-18 16:33
Core Viewpoint - Tianfeng Securities has conducted a special review regarding Guangdong Jushi Chemical Co., Ltd.'s return of raised funds and the use of remaining over-raised funds for permanent working capital supplementation, confirming compliance with relevant regulations and the interests of the company and its shareholders [1][7]. Summary by Sections 1. Basic Situation of Raised Funds - Guangdong Jushi Chemical was approved to publicly issue 23,333,334 shares at a price of RMB 36.65 per share, raising a total of RMB 855.1667 million, with a net amount of RMB 775.7297 million after deducting issuance costs of RMB 79.4370 million [1][2]. 2. Return of Temporarily Used Funds - The company temporarily used up to RMB 90 million of idle raised funds for working capital, which was approved by the board and returned to the special account by the date of the review [2][6]. 3. Investment Project Overview - The total investment amount for the projects funded by the raised funds is RMB 490.4617 million, with the net amount of raised funds being RMB 775.7297 million, resulting in a total over-raised amount of RMB 285.2680 million [2][4]. 4. Use of Over-raised Funds - The company plans to use RMB 43.5844 million of the remaining over-raised funds for permanent working capital, which accounts for 15.28% of the total over-raised funds [5][6]. 5. Compliance and Commitments - The company commits that the cumulative use of over-raised funds for permanent working capital will not exceed 30% of the total over-raised funds within any twelve-month period, ensuring that this will not affect the funding needs of investment projects [6][7]. 6. Review Procedures - The proposal for using the remaining over-raised funds for permanent working capital has been approved by the board and is pending submission to the shareholders' meeting for further approval [6][8]. 7. Sponsor's Review Opinion - Tianfeng Securities has no objections to the company's plan to use remaining over-raised funds for permanent working capital, confirming that the necessary review procedures have been followed and that there is no change in the purpose of the raised funds [7][8].
聚石化学: 前次募集资金使用情况专项报告
Zheng Quan Zhi Xing· 2025-08-18 16:30
Fundraising Overview - The company raised a total of RMB 855.17 million through its initial public offering, with a net amount of RMB 796.85 million after deducting issuance costs [1][2] - As of June 30, 2025, the remaining balance of the raised funds is RMB 52,004.35 [1][2] Fund Utilization - The company has utilized RMB 389.64 million for project investments and has allocated RMB 180.64 million from project completion surplus funds to supplement working capital [1][2] - The company has also temporarily supplemented working capital with RMB 240 million from idle raised funds, which has been returned to the special account as of August 2, 2023 [5][6] Project Changes - The implementation subject of the "Halogen-free Flame Retardant Expansion Project" has been changed from a subsidiary in Qingyuan to a subsidiary in Chizhou, with a total planned investment of RMB 12.02 million [2][9] - The "Chizhou Polystyrene Production Project" has been transferred to another subsidiary in Anqing, with the investment remaining at RMB 8 million [2][4] Financial Management - The company has invested RMB 121 million of idle raised funds in principal-protected financial products, yielding a total return of RMB 367,000 [7] - The company has also used part of the raised funds for cash management, ensuring that it does not affect the progress of investment projects [7] Economic Benefits - The "Halogen-free Flame Retardant Expansion Project" and "Polystyrene Production Project" are expected to generate significant economic benefits, with projected annual outputs and revenues [10][12] - The company reported that the production capacity utilization rates for these projects are in line with expectations, with the "Polystyrene Production Project" achieving a utilization rate of 58.40% in 2023 [12]
聚石化学: 广东聚石化学股份有限公司前次募集资金使用情况的鉴证报告
Zheng Quan Zhi Xing· 2025-08-18 16:30
Core Viewpoint - The report provides an overview of the fundraising activities and the utilization of funds by Guangdong Jushi Chemical Co., Ltd., highlighting the total amount raised, expenses incurred, and the current status of the funds as of June 30, 2025 [1][2]. Fundraising Overview - The total amount raised through the initial public offering (IPO) was RMB 855.17 million, with net proceeds amounting to RMB 775.73 million after deducting issuance costs of RMB 79.44 million [2][3]. - The funds were fully deposited into a designated account approved by the board of directors, and a regulatory agreement was signed with the sponsoring institution and the bank [2][3]. Fund Utilization - As of June 30, 2025, the total amount utilized from the raised funds was RMB 796.85 million, with various deductions for underwriting fees, pre-invested funds, and temporary working capital [2][3]. - The company has also temporarily supplemented working capital with idle funds, amounting to RMB 47.58 million, which was returned to the designated account by August 2, 2023 [5][6]. Project Changes - The implementation subject and location for the "Halogen-free Flame Retardant Expansion Project" were changed from a subsidiary in Guangdong to another in Anhui due to local regulatory constraints [3][7]. - The "Poly Styrene Production Project" was also relocated from Anhui to a different site in Anhui, reflecting strategic adjustments based on land availability and logistical considerations [4][7]. Financial Management - The company has engaged in cash management with idle funds, investing a total of RMB 121 million in low-risk financial products, yielding a return of RMB 367,042.51 [5][6]. - The company has also utilized excess funds for permanent working capital supplementation, with a total of RMB 80 million allocated for this purpose [6][7]. Economic Benefits - The projects funded by the raised capital are expected to generate significant economic benefits, although some projects, such as those for working capital and R&D, do not yield direct financial returns [8][12]. - The production capacity and output from the projects have been monitored, with the "Modified Plastic Expansion Project" achieving a production output of 23,358.52 tons in 2023, with a capacity utilization rate of 58.40% [12].
华之杰: 中信建投证券股份有限公司关于苏州华之杰电讯股份有限公司使用自有资金及银行承兑汇票等方式支付募投项目部分款项并以募集资金等额置换的核查意见
Zheng Quan Zhi Xing· 2025-08-17 16:11
中信建投证券股份有限公司 关于苏州华之杰电讯股份有限公司 (天健验〔2025〕 使用自有资金及银行承兑汇票等方式支付募投项目 部分款项并以募集资金等额置换的核查意见 中信建投证券股份有限公司(以下简称"中信建投"、"保荐人")作为苏州 华之杰电讯股份有限公司(简称"华之杰"、"公司")首次公开发行股票并在主 板上市的保荐人,根据《证券发行上市保荐业务管理办法》《上市公司募集资金 监管规则》 《上海证券交易所股票上市规则》 《上海证券交易所上市公司自律监管 指引第 1 号——规范运作》等有关法律法规和规范性文件的规定,对华之杰使用 自有资金及银行承兑汇票等方式支付募投项目部分款项并以募集资金等额置换 的事项进行了审慎核查,具体情况如下: 一、募集资金基本情况 中国证券监督管理委员会于 2025 年 4 月 9 日出具《关于同意苏州华之杰电 讯股份有限公司首次公开发行股票注册的批复》 (证监许可〔2025〕761 号),同 意公司向社会公众发行股票的注册申请。公司已向社会公众发行人民币普通股 (A 股)25,000,000 股,每股发行价格人民币 19.88 元,募集资金总额人民币 集资金净额为 444,164, ...
北京信安世纪科技股份有限公司第三届监事会第十次会议决议公告
Shang Hai Zheng Quan Bao· 2025-08-15 19:42
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:688201 证券简称:信安世纪 公告编号:2025-030 北京信安世纪科技股份有限公司 第三届监事会第十次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 北京信安世纪科技股份有限公司(以下简称"公司")第三届监事会第十次会议于2025年8月15日在公司 会议室以现场结合通讯方式召开,会议通知于2025年8月13日于书面方式通知给全体监事。会议应出席 监事5名,实际出席监事5名。本次会议由监事会主席汪宗斌先生主持。本次会议的召集和召开程序符合 《中华人民共和国公司法》等法律、法规、规章、规范性文件和《北京信安世纪科技股份有限公司章 程》《北京信安世纪科技股份有限公司监事会议事规则》的有关规定。 二、监事会会议审议情况 经与会监事表决,审议通过以下议案: (一)审议通过了《关于〈前次募集资金使用情况专项报告〉的议案》 《北京信安世纪科技股份有限公司前次募集资金使用情况报告》符合《公司法》《中华人民共和国证券 法》《上市公司证券 ...
必易微: 申万宏源证券承销保荐有限责任公司关于深圳市必易微电子股份有限公司使用募集资金向全资子公司实缴出资和提供借款以实施募投项目的核查意见
Zheng Quan Zhi Xing· 2025-08-15 16:35
Summary of Key Points Core Viewpoint - The company, Shenzhen Biyi Microelectronics Co., Ltd., is utilizing raised funds to make capital contributions and provide loans to its wholly-owned subsidiary for the implementation of investment projects, specifically the "Power Management Series Control Chip Development and Industrialization Project" [1][9]. Fundraising Overview - The company successfully raised a total of RMB 95,201.58 million by issuing 17,262,300 shares at RMB 55.15 per share, with a net amount of RMB 86,077.79 million after deducting issuance costs [1][2]. Investment Project Details - The total investment amount for the fundraising projects is RMB 65,251.50 million, with the "Biyi Micro R&D Center Construction Project" already completed and reaching a usable state [3][4]. Use of Funds for Subsidiary - The company plans to use RMB 5,000 million for capital contributions and up to RMB 3,000 million as interest-free loans to its subsidiary, Biyi Micro Shanghai, for the development and industrialization of power management chips [4][5][6]. Management of Raised Funds - A dedicated fund account will be established for the project, ensuring that the funds are used solely for the intended purpose, in compliance with relevant regulations [6][7]. Approval Process - The board of directors and the supervisory board have approved the use of funds, confirming that it aligns with legal requirements and does not alter the intended use of the raised funds [7][8][9].
科兴制药: 中信建投证券股份有限公司关于科兴生物制药股份有限公司使用部分募集资金向全资子公司提供无息借款以实施募投项目的核查意见
Zheng Quan Zhi Xing· 2025-08-15 16:24
Summary of Key Points Core Viewpoint - The company plans to use part of the raised funds to provide interest-free loans to its wholly-owned subsidiary for the implementation of fundraising projects, which has been reviewed and approved by the sponsor institution [1][9]. Fundraising Overview - The company raised a total of RMB 1,109.25 million through its initial public offering, with a net amount of RMB 994.64 million after deducting issuance costs [1]. - The total planned investment for the fundraising projects is RMB 1,771.79 million, with the company intending to allocate RMB 994.64 million from the raised funds [2]. Use of Funds - The company previously provided an interest-free loan of RMB 50 million to its subsidiary Shenzhen Kexing Pharmaceutical for the "R&D Center Upgrade Project" [2][3]. - The current plan includes an additional interest-free loan of RMB 20 million to the same subsidiary for ongoing R&D projects, bringing the total loan amount to RMB 120 million [4][5]. Project Progress - As of June 30, 2025, the cumulative investment in the R&D Center Upgrade Project is RMB 347.46 million, with RMB 290.63 million already utilized, resulting in a shortfall of RMB 56.83 million [4]. - The remaining balance in the dedicated fundraising account for this project is RMB 73.96 million, which includes net income from financial products and bank interest [4]. Financial Data of the Subsidiary - As of December 31, 2024, the subsidiary reported total assets of RMB 535.61 million, net assets of RMB 278.31 million, operating income of RMB 316.77 million, and net profit of RMB 51.75 million [7]. Approval Process - The use of funds for the interest-free loan has been approved by the company's board and supervisory board, complying with relevant regulations [9].
苏州西典新能源电气股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-08-14 19:12
Core Viewpoint - The company, Suzhou Xidian New Energy Electric Co., Ltd., has announced its 2025 mid-term profit distribution plan, proposing a cash dividend of 4.00 RMB per 10 shares, totaling approximately 62.74 million RMB, which represents 45.13% of the net profit attributable to shareholders for the first half of 2025 [25][26][28]. Group 1: Company Overview - The company is planning to establish a wholly-owned subsidiary named Suzhou Xidian New Energy Technology Co., Ltd. with a registered capital of 100 million RMB to enhance its technological product development [31][32]. - The company has also proposed to increase the registered capital of its wholly-owned subsidiary, Suzhou Xidian New Energy Automotive Electronics Co., Ltd., from 50 million RMB to 150 million RMB to support the implementation of fundraising projects [39][40]. Group 2: Financial Data - As of June 30, 2025, the company reported a net profit attributable to shareholders of 139.03 million RMB for the first half of 2025, with distributable profits amounting to 207.42 million RMB [26][28]. - The total share capital of the company is 161.6 million shares, with 4.75 million shares held in a repurchase account excluded from the dividend calculation [26][27]. Group 3: Board Meeting Decisions - The second board meeting on August 14, 2025, approved several key proposals, including the mid-term profit distribution plan, the establishment of a wholly-owned subsidiary, and the increase of capital for the subsidiary [5][6][8]. - The board also approved the use of self-owned funds to pay for part of the fundraising project costs, which will later be replaced with the raised funds [53][55]. Group 4: Audit and Compliance - The company has proposed to renew its audit engagement with Rongcheng Accounting Firm for the 2025 fiscal year, pending shareholder approval [62][75]. - The audit committee has reviewed and approved the renewal, confirming the firm's qualifications and independence [74][75]. Group 5: Employee Stock Ownership Plan - The board has approved the distribution of reserved shares under the first employee stock ownership plan, which does not require shareholder approval [79]. - This plan aims to align employee interests with company performance and enhance retention [79].
深圳微芯生物科技股份有限公司前次募集资金使用情况的专项报告
Shang Hai Zheng Quan Bao· 2025-08-14 19:01
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:688321 证券简称:微芯生物 公告编号:2025-047 深圳微芯生物科技股份有限公司 前次募集资金使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性依法承担法律责任。 根据中国证券监督管理委员会(以下简称"证监会")《监管规则适用指引一一发行类第7号》的规定, 深圳微芯生物科技股份有限公司(以下简称"公司"或"本公司")编制了截至2025年3月31日止的关于前 次募集资金使用情况的报告。 一、前次募集资金的募集及存放情况 (一)前次募集资金的数额、资金到账时间 根据中国证监会《关于同意深圳微芯生物科技股份有限公司向不特定对象发行可转换公司债券注册的批 复》(证监许可〔2022〕1234号),公司向不特定对象发行500万张可转换公司债券(以下简称"可转 债"),每张面值100元,募集资金总额为人民币500,000,000.00元,扣除与发行有关的费用总额人民币 15,462,700.00元后,实际募集资金净额为人民币484,537,300.00元。本次募集资金于 ...
网宿科技: 董事会决议公告
Zheng Quan Zhi Xing· 2025-08-14 09:09
Core Points - The board of directors of Wangsu Technology Co., Ltd. held its 27th meeting on August 14, 2025, to review and approve several key proposals related to the company's financial performance and operational activities [1][2]. Financial Performance - The company reported a total operating income of 786.13 million yuan, representing a year-on-year increase of 7.71% [1]. - The net profit attributable to shareholders of the listed company was 372.51 million yuan, showing a year-on-year growth of 25.33% [1]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was 261.40 million yuan, reflecting a year-on-year increase of 22.53% [1]. Board Resolutions - The board unanimously approved the 2025 semi-annual report and its summary, confirming that the report accurately reflects the company's financial status and operational results [2]. - A special report on the storage and use of raised funds for the first half of 2025 was also approved [2]. - The board agreed to provide guarantees for its wholly-owned subsidiary, Shanghai Yunshu Technology Co., Ltd., for a loan application to Shanghai Bank, with a total guarantee amount not exceeding 30 million yuan [3]. - The company decided to apply for a credit limit of 30 million yuan from Ningbo Bank, with the credit being renewable within a one-year term [3].